6 Macular Degeneration Clinical Trials in Fort Lauderdale, FL (2026)

Q: How do I join a clinical trial in Fort Lauderdale?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Lauderdale research site will contact you.

Recruiting Macular Degeneration Studies in Fort Lauderdale

NCT07440225Recruiting

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person...

Fort Lauderdale, FLPHASE2960 participantsEyeBiotech Ltd.

View Study Details

NCT07516132Recruiting

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants with Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 o...

Fort Lauderdale, FLPHASE3850 participantsOcular Therapeutix, Inc.

View Study Details

NCT06635148Recruiting

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ-81201887 administered in parent clinical studies....

Fort Lauderdale, FLPHASE2274 participantsJanssen Research & Development, LLC

View Study Details

NCT05197270Recruiting

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and tolerability of 4D-1...

Fort Lauderdale, FLPHASE1215 participants4D Molecular Therapeutics

View Study Details

NCT07205887Recruiting

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

EYE-RES-104 is a randomized, dose-masked study of intravitreal EYE103 in participants with neovascular age-related macular degeneration (NVAMD) or macular edema following branch retinal vein occlusion...

Fort Lauderdale, FLPHASE2160 participantsEyeBiotech Ltd.

View Study Details

NCT07630649Recruiting

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

The purpose of this study is to evaluate safety, effectiveness and durability of a gene therapy called Ixo-vec (Ixoberogene soroparvovec) when administered to the contralateral (second) eye of adult p...

Fort Lauderdale, FLPHASE215 participantsAdverum Biotechnologies, Inc.

View Study Details

About Macular Degeneration Clinical Trials in Fort Lauderdale

Age-related macular degeneration (AMD) is the leading cause of severe vision loss in Americans over 50, affecting over 11 million people. Wet (neovascular) AMD involves abnormal blood vessel growth under the retina, while dry AMD involves gradual thinning of the macula and accumulation of drusen deposits. Current treatment for wet AMD relies on anti-VEGF injections (ranibizumab, aflibercept, faricimab), with newer high-dose and extended-interval formulations reducing treatment burden. For geographic atrophy (advanced dry AMD), complement inhibitors like pegcetacoplan (Syfovre) represent the first approved treatments. Clinical trials are testing gene therapies, implantable drug delivery systems, stem cell therapies, and novel targets beyond VEGF for both wet and dry AMD.

There are currently 6 macular degeneration clinical trials recruiting participants in Fort Lauderdale, FL. These studies are seeking a combined 2,474 participants. Research is being sponsored by EyeBiotech Ltd., Ocular Therapeutix, Inc., Janssen Research & Development, LLC and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Macular Degeneration Clinical Trials in Fort Lauderdale — FAQ

Are there macular degeneration clinical trials in Fort Lauderdale?

Yes, there are 6 macular degeneration clinical trials currently recruiting in Fort Lauderdale, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fort Lauderdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Lauderdale research site will contact you about next steps.

Are clinical trials in Fort Lauderdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fort Lauderdale studies also compensate for your time and travel.

What macular degeneration treatments are being tested?

The 6 active trials in Fort Lauderdale are testing new therapies including novel drugs, biologics, and treatment approaches for macular degeneration.

Data updated October 15, 2026 from ClinicalTrials.gov